WILLIAM IVESON: Open Payments
NPI 1205232709 · SUSQUEHANNA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 37 payments from 14 companies in 2025. Trend: 2023 $669 · 2024 $620 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $138 |
| Braeburn Inc. | 6 | $100 |
| Neurocrine BioSciences, Inc. | 5 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 |
| Exact Sciences Corporation | 2 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Astellas Pharma US Inc | 2 | $36 |
| Indivior Inc. | 2 | $32 |
| PFIZER INC. | 1 | $22 |
Products named: FANAPT, BRIXADI, INGREZZA, CAPLYTA, The Cologuard Plus Collection Kit, AUSTEDO XR, INVEGA SUSTENNA, Veozah.
Industry payments across PA — which companies pay providers there.
